Nurse Edition Latest Issue TOC
Healthcare providers are long overdue for some in-depth help when it comes to talking with patients and families during times of personal tragedy.
FROM THE EDITOR
Back to Basics: Communication 101Deborah A. Boyle, RN, MSN, AOCNS, FAAN
Healthcare providers are long overdue for some in-depth help when it comes to talking with patients and families during times of personal tragedy.
COVER STORY
Metastatic Colorectal Cancer: Management Challenges and Opportunities
Gail M. Wilkes, MS, APRN-BC, AOCN
CME
Advances in the multidisciplinary management of metastatic colorectal cancer have improved survival considerably, and nurses are key to optimal patient care.
• Article Reviewed: The Evolving Care of Metastatic Colorectal Cancer
INTEGRATIVE ONCOLOGY
Acupuncture in Cancer Care
Gary Deng, MD, PhD, Barrie Cassileth, PhD
Acupuncture is a therapeutic modality in Traditional Chinese Medicine (TCM), developed over the millennia. Treatment involves the placement of needles at selected points on the body, followed by manipulation with physical forces, heat, or, in modern times, electrical stimuli.
DRUG ESSENTIALS
Ipilimumab, a Human Monoclonal Antibody for Treatment of Unresectable or Metastatic Melanoma
Gail M. Wilkes, MS, APRN-BC, AOCN
Ipilimumab is a human monoclonal antibody that blocks cytotoxic T-lymphocyte antigen 4 (CTLA-4). CTLA-4 normally turns off activation of the powerful cytotoxic T cells, which are able to kill cancer cells.
CASE STUDY
Invasive Aspergillosis in an Allogeneic Hematopoietic Cell Transplant Patient
Laura Zitella, RN, MS, ACNP, AOCN
Invasive aspergillosis is a major cause of life-threatening infection in immunocompromised patients. Nurses are well positioned to identify, educate, and monitor patients at high risk.
ONLINE EXCLUSIVES
Polypharmacy in Older Adult Cancer PatientsDeborah A. Boyle, RN, MSN, AOCNS, FAAN
Older patients may fail to consume their medications as prescribed because of faulty memory, a lack of understanding about the treatments they are being given and their importance, or concerns about cost.
• The Older Cancer Patient
: Resources for Care
• News of Note
: Literature Highlights
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
![“If you have a [patient in the] fourth or fifth line, [JNJ-5322] could be a valid drug of choice,” said Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD.](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2F267879fc15a40ec8d3ed04d8ee9c1f044b49ee89-2990x1692.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 "“If you have a [patient in the] fourth or fifth line, [JNJ-5322] could be a valid drug of choice,” said Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD.")
